Trial Site Detail

 

Drug:	Nilotinib or Imatinib
Trial:	Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Completed

 

National Cancer Center Hospital       Chuo-ku , Tokyo 104-0045 Japan

 

Principal Investigator:	Yasuhide Yamada, MD
Contact:	Yasuhide Yamada, MD +81 33 542 5111 yayamada@ncc.go.jp
Activation Status of this Site:	Closed
Notes about this Site:
National Cancer Center Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.